SPL RF Jan 2021
EN_01459393_0319
![SPL RF Jan 2021](img/medium/arch35/dvd0424/67/EN_01459393_0319.jpg)
SPECIAL RATES FOR EDITORIAL AND BOOKS
RF RATES FOR OTHER USE - INTERNET +100%
Internet +100%
RNA vaccine, conceptual illustration. Close-up of human cells expressing viral proteins (red) after vaccination with an RNA (ribonucleic acid, blue helix) vaccine. The viral proteins will provoke an immune response, priming the body against infection with the actual virus. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.
2021-01-02
DESIGN CELLS/Science Photo Library RF/East News
Science Photo Library RF
DESIGN CELLS
f0325890
6,11MB
61cm x 34cm by 300dpi
1ST, ACID, ANTIGEN, ARTWORK, BIOLOGICAL, BIOLOGY, BIONTECH, BIOTECHNOLOGICAL, BIOTECHNOLOGY, BODY, CELLS, CONCEPTS, CONCEPTUAL, CONDITION, CORONAVIRUS, COVID-19, DESIGN, DISEASE, DISORDER, EPIDEMIC, FIRST, HCOV, HUMAN, ILLUSTRATION, IMMUNISATION, IMMUNISING, IMMUNITY, IMMUNIZING, MESSENGER, MRNA, NO-ONE, NOBODY, PANDEMIC, PFIZER, PROTEIN, RIBONUCLEIC, RNA, SARS-COV, SARS-COV-2, VACCINATING, VACCINATION, VACCINE, VIRAL,